跳至主要内容
临床试验/NCT01205789
NCT01205789已完成不适用

EXCEL Clinical Trial (Universal Registry)

Abbott Medical Devices1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2010年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,000
试验地点
1
主要终点
This study has no Primary outcome measure, it is an observational study to collect information on subjects not randomized to the RCT portion of the study.

研究概览

简要总结

The purpose of the Universal Registry is to assess the proportion and reasons for which subjects with angiographically significant ULMCA disease requiring revascularization during the time course of this study are not randomized; to compare the baseline characteristics of subjects; and to assess the variability in randomization eligibility and treatment patterns.

详细描述

Approximately 100 consecutive subjects who otherwise meet all enrollment criteria, will be analyzed separately as intermediate lesion subjects, and will be followed through the time of initial treatment per standard of care with intended PCI, CABG or medical treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects who are either not eligible for randomization or for other reasons are not randomized will be consented for the Universal Registry

排除标准

  • 未提供

结局指标

主要结局

This study has no Primary outcome measure, it is an observational study to collect information on subjects not randomized to the RCT portion of the study.

时间窗: At the time of enrollment into the study

The purpose of the Universal Registry is to assess the proportion and reasons for which subjects with angiographically significant ULMCA disease requiring revascularization during the time course of this study are not randomized; to compare the baseline characteristics of subjects; and to assess the variability in randomization eligibility and treatment patterns. There are no follow-up time points for this study.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验